| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.25 | 0.06 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |